Randall F. Holcombe, MD, MBA, Named UVM Cancer Center Director & Hematology/Oncology Division Chief

Randall F. Holcombe, M.D., M.B.A. (Courtesy photo)

The Larner College of Medicine at the University of Vermont (UVM), in collaboration with the UVM Health Network (UVMHN) and the UVM Medical Center, has announced that Randall F. Holcombe, M.D., M.B.A., has been appointed director of the UVM Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. Holcombe is expected to hold the newly established J. Walter Juckett Chair in Cancer Research. He joins UVM and UVMHN from the National Cancer Institute (NCI)-designated University of Hawai'i Cancer Center, where he has held the post of director since 2016. He succeeds Richard Galbraith, M.D., Ph.D., and Chris Holmes, M.D., Ph.D., who became interim co-directors of UVMCC in 2020, with Holmes also serving as interim chief of the Division of Hematology and Oncology since 2017. Holcombe will officially begin his tenure August 1, 2021. View the full article here.

A Day in the Life of Your Cancer Center

The UVM Cancer Center presents this short video to remind us all of the extraordinary efforts and collegiality of those who make up and support us. During the last 17 months, we have survived COVID, a cyber-attack and uncertainty about the future. It is easy for the daily challenges of life to overshadow the real opportunities and successes we have had in moving forward the science of the treatment and prevention of cancer. But rest assured, to our patients and their families, your dedication and compassion has been an anchor in the storm.

SAVE THE DATE: Friday, October 1, 2021 for the 24th Annual Women's Health and Cancer Conference a Virtual Event

While we look forward to hosting an in-person event when it is safe to do so, the 2021 conference will again be hosted as a virtual event in order to preserve the safety and comfort of participants.

View the Women's Health and Cancer Conference webpage soon for more information about speakers, topics, and how to register. Spread the word!

24th Annual Women's Health & Cancer Conference postcard

Advancing Cancer Research and Care

The physicians, scientists, caregivers and staff at the University of Vermont Cancer Center are dedicated to advancing the prevention, detection, treatment, and survivorship of cancer by providing state-of-the art cancer diagnosis and treatment, delivering compassionate cancer care, providing education to patients and the community, and advancing innovative research from the laboratory to the patient.

Patients and Community

Patricia J. O'Brien, M.D. and patient

The University of Vermont Cancer Center physicians and scientists work together to translate the latest research findings into life-saving care for our patients. This has enabled us to use revolutionary treatments for many forms of cancer, offer a new lease on life for children with a rare form of cancer, and reduce the side effects of chemotherapy.

Learn more about patient care & support

Research Achievements

Ted James, M.D.

The University of Vermont Cancer Center is home to many different research programs that help us to understand the causes of cancer and to strive for a cure. We have research covering all tumor types and cancer-related fields. Particular emphasis is placed on the delivery of cancer screening and treatment to rural and underserved populations.

Learn more about UVM Cancer Center research.

Conferences and Events

Two faculty attend a conference

The University of Vermont Cancer Center hosts numerous events throughout the year targeted at both the general public and health care providers. These events and conferences allow providers to stay up-to-date on the latest innovations and research, and also provide education and support to those in the cancer community.

Learn more about UVM Cancer Center events.

ASK THE EXPERT: News from the UVM Cancer Center

Community Advisory Board member Natalie Harder, talks to UVM Cancer Center tobacco use researcher and expert, Andrea Villanti, PhD, MPH, about the significance of youth tobacco use and cancer risk.